Detalhe da pesquisa
1.
Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat.
Haematologica
; 106(9): 2397-2404, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32732354
2.
Targeting Telomere Biology in Acute Lymphoblastic Leukemia.
Int J Mol Sci
; 22(13)2021 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34206297
3.
International external quality assurance of JAK2 V617F quantification.
Ann Hematol
; 98(5): 1111-1118, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30535576
4.
Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.
N Engl J Med
; 373(10): 920-8, 2015 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26332546
5.
Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and CEP110-FGFR1 Rearrangement.
Oncologist
; 22(4): 480-483, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28242791
6.
Molecular diagnostics of myeloproliferative neoplasms.
Eur J Haematol
; 95(4): 270-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25951317
7.
Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia.
Ann Hematol
; 92(2): 173-7, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23161387
8.
Higher Age (≥60 Years) Increases the Risk for Adverse Events during Autologous Hematopoietic Stem Cell Transplantation.
Cancers (Basel)
; 15(5)2023 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900376
9.
Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias.
BMC Med Genomics
; 15(1): 203, 2022 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36138464
10.
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.
Leukemia
; 36(7): 1834-1842, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35614319
11.
Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial.
Lung Cancer
; 156: 91-99, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33933896
12.
[Molecular analyses for (early) recognition of hematologic diseases - sense and sensibility for molecular analysis: the art of intelligent decision-making]. / Molekulare (Früh)-Erkennung in der Hämatologie - Sinn oder Unsinn molekularer Analytik: Die Kunst der richtigen Wahl.
Ther Umsch
; 67(7): 349-58, 2010 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-20577963
13.
Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.
Leukemia
; 32(5): 1222-1228, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29479070
14.
Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases.
Haematologica
; 91(11): 1465-72, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17082007
15.
Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction.
Haematologica
; 90(7): 875-80, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15996924
16.
Excellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemia.
Bone Marrow Transplant
; 55(8): 1690-1693, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796871
17.
Imetelstat inhibits growth of megakaryocyte colony-forming units from patients with essential thrombocythemia.
Blood Adv
; 3(22): 3724-3728, 2019 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31770436
18.
Coincidence of 5q deletion and the JAK2V617F mutation: report of two patients with overlapping myelodysplastic and myeloproliferative features and review of the literature.
Leuk Lymphoma
; 59(9): 2233-2237, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29295644
19.
CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms.
Leuk Res
; 36(9): 1204-7, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22738889
20.
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05).
Lung Cancer
; 78(3): 239-44, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23009726